An Overview of Phenserine Tartrate, A Novel Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 2, Iss. 3, 2005-07 ,pp. : 281-290

Bentham Science Publishers

Access to resources Recommend Favorite

Immunological approach for the treatment of Alzheimer’s disease

By Solomon Beka  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 283-286

Humana Press, Inc

Access to resources Recommend Favorite

Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease

By Greenblatt Harry   Dvir Hay   Silman Israel   Sussman Joel  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 369-383

Humana Press, Inc

Access to resources Recommend Favorite

A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 5, 2014-06 ,pp. : 413-421

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant treatment in alzheimer’s disease: Current state

By Gilgun-Sherki Yossi   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 21, Iss. 1, 2003-09 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite